Tag: Dr Dana McClintock

Alladapt Harmony Study

Alladapt’s 15-Allergen OIT Candidate Ready to Begin Phase 1/2 Study

ADP101 is intended to treat patients with an allergy to one or more of peanut, almond, hazelnut, cashew, pistachio, pecan, walnut, milk, egg, cod, salmon, shrimp, wheat, soy, and sesame.
Alladapt

Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...

Company is developing therapy to target a number of food allergies simultaneously.